Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Feb 27, 2015

30339_dirs_2015-02-27_1b65da96-bb4f-4c3a-87d2-0a3d0db6d108.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-26

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-26 Common Stock M 4682.0000 $16.2925 Acquired 75850.0700 Direct
2015-02-26 Common Stock S 4682.0000 $54.9250 Disposed 71168.0700 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-26 Stock Option (Right to Buy) $16.2925 M 4682.0000 Disposed 2016-02-24 Common Stock (4682.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 908.3538 Indirect
Common Stock 7302.7700 Indirect